CCO Expert Recap

Update From 2006 CROI: First-line Therapy, Pharmacology, Metabolics

Source: CCO Independent Conference Coverage of the 2006 Conference on Retroviruses and Opportunistic Infections*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update From 2006 CROI: First-line Therapy, Pharmacology, Metabolics

Faculty:

Joel E. Gallant, MD, MPH
Richard E. Chaisson, MD
Joseph J. Eron, Jr., MD

Courtney V. Fletcher, PharmD
W. David Hardy, MD
Sally Hodder, MD

Bruce Polsky, MD
Mauro Schechter, MD, PhD
Kimberly Y. Smith, MD, MPH

Kathleen E. Squires, MD
Andrew R. Zolopa, MD

CME CREDIT INFORMATION

Release Date: 03/31/06

Expiration Date: 03/30/07

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

List the recently reported results of clinical and basic studies of all classes of antiretroviral therapy agents used in the treatment of HIV
Discuss the epidemiology and pathogenesis of lipodystrophy
Describe strategies for management of lipodystrophy and complications occuring in patients receiving antiretroviral therapy
Review new evidence concerning pharmacologic interactions and side effects that may occur in patients receiving antiretroviral therapy

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.